Table 2.
Frequency distribution and chi-square analysis of the vaccine demand group (immediate or delayed acceptance).
| Variable | Immediate acceptance 169 (49.71%) | Delayed acceptance 171 (50.29%) | Total | P-value | |||
|---|---|---|---|---|---|---|---|
| Age | |||||||
| 18–29 | 38 | (22.49%) | 42 | (24.56%) | 80 | (23.53%) | 0.899 |
| 30–39 | 73 | (43.20%) | 74 | (43.27%) | 147 | (43.24%) | |
| 40–49 | 40 | (23.67%) | 39 | (22.81%) | 79 | (23.24%) | |
| 50–59 | 11 | (6.51%) | 12 | (7.02%) | 23 | (6.76%) | |
| ≥60 | 7 | (4.14%) | 4 | (2.34%) | 11 | (3.24%) | |
| Gender | |||||||
| Female | 47 | (27.81%) | 65 | (38.01%) | 112 | (32.94%) | 0.045** |
| Male | 122 | (72.19%) | 106 | (61.99%) | 228 | (67.06%) | |
| Marital status | |||||||
| Unmarried | 50 | (29.59%) | 56 | (32.75%) | 106 | (31.18%) | 0.529 |
| Married | 119 | (70.41%) | 115 | (67.25%) | 234 | (68.82%) | |
| Location | |||||||
| Central | 18 | (10.65%) | 25 | (14.62%) | 43 | (12.65%) | 0.370 |
| South | 43 | (25.44%) | 43 | (25.15%) | 86 | (25.29%) | |
| East | 19 | (11.24%) | 13 | (7.60%) | 32 | (9.41%) | |
| North | 4 | (2.37%) | 9 | (5.26%) | 13 | (3.82%) | |
| West | 85 | (50.30%) | 81 | (47.37%) | 166 | (48.82%) | |
| Monthly income | |||||||
| < SR 3,000 | 17 | (10.06%) | 26 | (15.20%) | 43 | (12.65%) | 0.657 |
| SR 3,000 to < SR 5,000 | 9 | (5.33%) | 8 | (4.68%) | 17 | (5%) | |
| SR 5,000 to < SR 7,000 | 8 | (4.73%) | 14 | (8.19%) | 22 | (6.47%) | |
| SR 7,000 to < SR 10,000 | 21 | (12.43%) | 18 | (10.5%3) | 39 | (11.47%) | |
| SR 10,000 to < SR 15,000 | 54 | (31.95%) | 45 | (26.32%) | 99 | (29.12%) | |
| SR 15,000 to < SR 20,000 | 31 | (18.34%) | 33 | (19.30%) | 64 | (18.82%) | |
| SR 20,000 to < SR 30,000 | 16 | (9.47%) | 13 | (7.60%) | 29 | (8.53%) | |
| ≥SR 30,000 | 13 | (7.69%) | 14 | (8.19%) | 27 | (7.94%) | |
| Frontline healthcare worker | |||||||
| No | 70 | (41.42%) | 87 | (50.88%) | 157 | (46.18%) | 0.080* |
| Yes | 99 | (58.58%) | 84 | (49.12%) | 183 | (53.82%) | |
| Having chronic conditions | |||||||
| No | 127 | (75.15%) | 143 | (83.63%) | 270 | (79.41%) | 0.0530* |
| Yes | 42 | (24.85%) | 28 | (16.37%) | 70 | (20.59%) | |
| Received flu vaccination in the past | |||||||
| No | 35 | (20.71%) | 44 | (25.73%) | 79 | (23.24%) | 0.2730 |
| Yes | 134 | (79.29%) | 127 | (74.27%) | 261 | (76.76%) | |
| Refused vaccination in the past | |||||||
| No | 158 | (93.49%) | 154 | (90.06%) | 312 | (91.76%) | 0.250 |
| Yes | 11 | (6.51%) | 17 | (9.94%) | 28 | (8.24%) | |
| Infected with COVID-19 | |||||||
| No | 141 | (83.43%) | 137 | (80.12%) | 278 | (81.76%) | 0.429 |
| Yes | 28 | (16.57%) | 34 | (19.88%) | 62 | (18.24%) | |
| Family infected with COVID-19 | |||||||
| No | 106 | (62.72%) | 95 | (55.56%) | 201 | (59.12%) | 0.179 |
| Yes | 63 | (37.28%) | 76 | (44.44%) | 139 | (40.88%) | |
| Friends infected with COVID-19 | |||||||
| No | 14 | (8.28%) | 13 | (7.60%) | 27 | (7.94%) | 0.816 |
| Yes | 155 | (91.72%) | 158 | (92.40%) | 313 | (92.06%) | |
| Perceived risk of COVID-19 to people in Saudi Arabia | |||||||
| Minor risk or no risk | 28 | (16.57%) | 24 | (14.04%) | 52 | (15.29%) | 0.217 |
| Moderate risk | 51 | (30.18%) | 67 | (39.18%) | 118 | (34.71%) | |
| Significant or major risk | 90 | (53.25%) | 80 | (46.78%) | 170 | (50.00%) | |
| Concerned about getting infected with COVID-19 | |||||||
| Low or very low | 52 | (30.77%) | 72 | (42.11%) | 124 | (36.47%) | 0.081* |
| Fair | 57 | (33.73%) | 52 | (30.41%) | 109 | (32.06%) | |
| High or very high | 60 | (35.50%) | 47 | (27.49%) | 107 | (31.47%) | |
| A COVID-19 vaccine should be compulsory for all citizens and residents inside Saudi Arabia | |||||||
| No | 26 | (15.38%) | 66 | (38.60%) | 92 | (27.06%) | 0.000*** |
| Yes | 143 | (84.62%) | 105 | (61.40%) | 248 | (72.94%) | |
***
p < 0.01,
**
p < 0.05,
*
p < 0.1.